This report contains market size and forecasts of Next-Generation Breast Cancer Diagnostic and Screening in Global, including the following market information:

Global Next-Generation Breast Cancer Diagnostic and Screening Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Next-Generation Breast Cancer Diagnostic and Screening market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Next-Generation Breast Cancer Diagnostic and Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.


Total Market by Segment:

Global Next-Generation Breast Cancer Diagnostic and Screening Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, By Type, 2020 (%)

Real-Time PCR (q-PCR)

Immunohistochemistry (IHC)

Next-Generation Sequencing (NGS)

Fluorescent In-Situ Hybridization (FISH)

China Next-Generation Breast Cancer Diagnostic and Screening Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, By Application, 2020 (%)

Hospital-associated Labs

Cancer Research Institutes

Diagnostic Centers

Global Next-Generation Breast Cancer Diagnostic and Screening Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, By Region and Country, 2020 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa


Competitor Analysis

The report also provides analysis of leading market participants including:

Total Next-Generation Breast Cancer Diagnostic and Screening Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Next-Generation Breast Cancer Diagnostic and Screening Market Competitors Revenues Share in Global, by Players 2020 (%)


Further, the report presents profiles of competitors in the market, including the following:

Abbott Laboratories

Agendia

Agilent Technologies

Ambry Genetics

Biocept

Biotheranostics

Centogene

Danaher Corporation

EXACT Sciences Corporation

Roche Holding AG

Fulgent Genetics

Illumina

Invitae

Lucence Diagnostics Pte Ltd

Myriad Genetics